News
bioMérieux, a world leader in the field of in vitro diagnostics, today announces the launch of SMARTBIOME™, an innovative solution designed to help food manufacturers better understand, control and prevent microbiological spoilage. By combining high‑precision DNA sequencing, advanced bioinformatics and bioMérieux’s microbiology expertise, SMARTBIOME™ provides actionable insights to protect product quality, reduce waste and better preserve consumer safety.
Swipe to discover more
-
bioMérieux Acquires Accellix to Elevate Pharmaceutical Quality Control and Accelerate Advanced Therapies
bioMérieux, a world leader in the field of in vitro diagnostics, announces the acquisition of Accellix, a US company specializing in rapid, automated flow cytometry solutions for cell and gene therapy quality control. With this strategic transaction, bioMérieux strengthens its Pharmaceutical Quality Control activity and invests in innovative solutions that will support the growing advanced therapy market and improve patient outcomes worldwide. -
Is Flu/COVID/RSV Testing Enough? A Comparison of Multiplex Respiratory Testing
This articles features a comparison of the performance of BIOFIRE® SPOTFIRE® Respiratory/Sore Throat (R/ST) Panel, Cepheid Xpert® Xpress SARS-CoV-2/Flu/RSV, and Cobas® SARS-CoV-2 & Influenza A/B assay for detection of respiratory viruses.
-
Rising to the Challenge: Harnessing Diagnostics to Combat Infectious Diseases and AMR
Global health leaders unite to unlock the value of diagnostics in the fight against antimicrobial resistance.
Enabling Decision-Making
- BIOMÉRIEUX ESHOP
- ANTIMICROBIAL STEWARDSHIP
- SEPSIS
- FOOD SAFETY & QUALITY
- PHARMA QUALITY CONTROL
- COVID-19
- BIOMÉRIEUX ESHOP
- ANTIMICROBIAL STEWARDSHIP
- SEPSIS
- FOOD SAFETY & QUALITY
- PHARMA QUALITY CONTROL
- COVID-19